ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolotin, S.
Right arrow Articles by Drews, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolotin, S.
Right arrow Articles by Drews, S. J.
Annals of Clinical & Laboratory Science 39:155-159 (2009)
© 2009 Association of Clinical Scientists

Validation of the TaqMan Influenza A Detection Kit and a Rapid Automated Total Nucleic Acid Extraction Method to Detect Influenza A Virus in Nasopharyngeal Specimens

Shelly Bolotin1, Cedric De Lima1, Kam-Wing Choi1, Ernesto Lombos1, Laura Burton1, Tony Mazzulli1,2,3 and Steven J. Drews1,2,3
1 Ontario Public Health Laboratories, 2 Department of Microbiology, Mount Sinai Hospital, and 3 Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Address correspondence to Dr. Shelly Bolotin, Ontario Public Health Laboratories, Molecular Diagnostics, 81 Resources Road, Etobiocoke, Ontario M9P 3T1, Canada; tel 416 235 6504; fax 416 235 6550; e-mail shelly.bolotin{at}ontario.ca.

This study describes the validation of the TaqMan® Influenza A Detection Kit v2.0 combined with an automated nucleic acid extraction method. The limit of detection of this assay was determined by probit regression (95% confidence interval) to be 2 influenza A/PR/8/34 (H1N1) virus particles per microlitre. One hundred and eleven specimens previously tested using the Seeplex® RV assay and viral culture methods were tested using the TaqMan Influenza A Detection Kit. Compared to the aggregate gold-standard, the sensitivity and specificity of the TaqMan Influenza A Detection Kit were 100% (35/35) and 97% (74/76), respectively. Because of its accuracy, quick turn-around-time and lyophilized bead form, the TaqMan Influenza A Detection Kit, combined with the NucliSense® easyMAGTM automated extraction method, constitutes a reliable protocol for influenza A diagnosis.

Keywords: influenza, respiratory viruses, pandemic preparedness, molecular diagnostics






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association of Clinical Scientists.